Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122719) titled 'Nab-paclitaxel plus Gemcitabine and Anlotinib in the Treatment of Non-cutaneous Angiosarcoma: A Clinical Study (NPGAAS)' on April 16.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhongshan Hospital,Fudan University
Condition:
Angiosarcoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-19
Target Sample Size: Intervention group:43;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=318285
Published by HT Digital Content Services with permission from Health Daily Digest....